glp-1 summit medications can support meaningful weight loss—but without proper movement and nutrition guidance, patients may also experience muscle loss and rebound effects. Rehab professionals play a key role in helping preserve strength 2nd GLP-1-Based Therapeutics Summit 2025

In response to LPS, the increase in GLP-1 is dose dependent, and GLP-1 levels remain elevated for 8-h (111)

More recently, two dual-acting GLP-1/GIP agonists have been approved, Mounjaro (tirzepatide) for type 2 diabetes and Zepbound (tirzepatide) for chronic weight management

Al-Thomali et al

According to GlobalData, the top GLP-1 drugs are still in shortage in the U.S., Europe and Australia as demand has increased from a large worldwide patient population

Compounding drugs to meet demand Big Easy Weight Loss has contracts with five compounding pharmacies, which are able to make the injections and deliver them on ice to a prescribers doorstep using the same active ingredient in the brand-name drugs